M.S, M.B.A, Chief Business Officer & Head of Biopharma, Foundation Medicine
Melanie joined Foundation Medicine in 2016 as chief business officer and head, Biopharma. She brings more than 25 years of experience in corporate strategy and business development. Previously, Melanie was senior vice president, corporate strategy and business development, McKesson Distribution Solutions and McKesson Data & Analytics. She was responsible for identifying growth opportunities and working closely with the executive committee and operating team to drive business growth, financial performance and strategy execution. She was also senior vice president, corporate development at Geron Corporation and a partner and senior member of the global health practice at Booz & Company/Booz Allen Hamilton. She has been on the board of the American Red Cross Bay Area Chapter, Bay Area Council and Healthcare Business Women’s Association. Melanie earned her MBA with honors from Columbia Business School, and her MS in business and economics from WHU Otto Beisheim School of Corporate Management in Koblenz, Germany.
Session Abstract – PMWC 2018 Silicon Valley
Session Synopsis: As Next Generation Sequencing continues to outpace Moores Law it’s broad adoption in a clinical environment still faces several barriers to entry, namely complexity in workflow and reimbursement. To economically enable value based healthcare, technology providers need to think bigger and reimbursement needs to be more broadly understood and simplified. Come hear from our expert panelists about their thoughts on the current state of reimbursement, where things are moving and how individuals not directly involved in reimbursement can influence and expedite change.